Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
M-9140 by Merck for Metastatic Colorectal Cancer: Likelihood of Approval
M-9140 is under clinical development by Merck and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
Data Insights
M-9140 by Merck for Solid Tumor: Likelihood of Approval
M-9140 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...